District Court Closes the Door Permanently on Wickfire’s Meritless Claims

After Wickfire suffered a devastating loss at the Fifth Circuit Court of Appeals, Wickfire nonetheless continued pursuing meritless claims at a District Court. The District Court rejected Wickfire’s attempts and dismissed Wickfire’s claims permanently. This ends Wickfire’s eight-year lawsuit and provides TriMax with complete vindication

AUSTIN, Texas, April 04, 2022 (GLOBE NEWSWIRE) — Wickfire suffered the latest in an extensive line of litigation defeats to TriMax. This time, a District Court dismissed Wickfire’s meritless claims permanently.

In 2021, an Appellate Court ruled that Wickfire lacked any evidence supporting its multi-million-dollar claims against TriMax. Undeterred by this monumental loss, Wickfire tried its hand once more and failed.

After losing at the Appellate Court, Wickfire moved a District Court to order TriMax pay Wickfire more than $400,000. This led to a flurry of findings and orders against Wickfire:

  • In February 2022, Federal Magistrate Judge Susan Hightower found that Wickfire’s motion lacked merit. In reaching her determination, the Magistrate Judge recognized “excessive costs and delays” due to Wickfire’s “litigation tactics.”
  • After that, United States District Judge Robert Pitman issued an Order agreeing with the Magistrate Judge’s findings and fully denied Wickfire’s motion.
  • On March 15, 2022, the Western District of Texas issued a Final Judgment, finding that Wickfire shall “TAKE NOTHING” on all its claims against TriMax and its principals.
  • In the same “TAKE NOTHING” judgment, the District Court declared that Wickfire’s claims shall be “DISMISSED WITH PREJUDICE,” thereby preventing Wickfire from continuing to assert its meritless claims against TriMax in the future.

The orders and findings appear in published opinions from the Fifth Circuit Court of Appeals, Case Number 17-3043040 and the United States District Court for the Western District of Texas, Case No. 1:14-CV-0034-RP.

The lawsuit centered around Google AdWords Auctions, an online-auction platform where companies like TriMax and Wickfire compete for advertising space. Wickfire asserted a series of claims against TriMax, but as to each one, Wickfire failed. Wickfire alleged TriMax intentionally interfered with Wickfire’s contracts, intentionally interfered with Wickfire’s prospective business, and committed civil conspiracy. An Appellate Court found “Wickfire offered no such proof” and declared that each of these claims failed.

After the Appellate Court found an earlier District Court judgment awarding $2.3 million to Wickfire to be erroneous due to the lack of any supporting evidence, the District Court more recently issued the “TAKE NOTHING” judgment. Through the “TAKE NOTHING” judgment, Wickfire received no award and, conversely, was ordered to pay its own attorneys’ fees and costs.

In the same lawsuit, the jury previously found Wickfire LLC and its co-owners, Chet Hall and Jon Brown, to have intentionally interfered with TriMax Media’s business. TriMax argued that Wickfire intentionally interfered with TriMax’s contracts by (1) paying kickbacks to merchant representatives in exchange for exclusivity agreements; (2) impersonating TriMax by placing unauthorized ads that plagiarized TriMax’s ad copy and contained other identifying information of TriMax; (3) repeatedly clicking on TriMax ads in order to artificially increase TriMax’s costs (known as “click fraud”); and (4) using an automated software program to manipulate the Google auction system (known as “bid jamming”).

TriMax presented evidence to the jury that Wickfire had been suspended from over 200 Google accounts, violated merchant terms, and employed fake user agents and proxies to conceal its identity. The jury also saw evidence that Google referred to Wickfire as “Known Fraudsters” and that Wickfire registered the domain name “GoogleClickFraud.com”.

TriMax also presented evidence regarding Wickfire’s destruction of evidence. During the litigation, Wickfire wiped all the data from its Chief Technology Officer, Jon Brown’s, laptop and then failed to disclose that information to TriMax or the District Court. Once TriMax uncovered the destruction, Wickfire claimed it was necessary, since the laptop had been stolen during a home burglary. However, the police report—which TriMax obtained independently after Wickfire failed to produce a copy—contradicted Wickfire’s story because it mentioned nothing about an allegedly stolen laptop.

While the jury heard extensive evidence about Wickfire’s conduct comprising Wickfire’s intentional interference against TriMax (which the jury found to have occurred), some of the most devastating evidence was excluded. For example, the jury was not permitted to see:

  • The police report from the burglary;
  • Registration documents showing Wickfire as the owner of “BitchesOfFacebook.com” and “PokeBitches.com”;
  • An e-mail from a merchant representative who, after refusing to accept the alleged kickbacks, referred to Wickfire as “criminals”;
  • Screenshots of Wickfire’s ads impersonating TriMax’s;
  • An e-mail from a merchant terminating TriMax after wrongly believing TriMax was the source of the impersonating ads;
  • An e-mail from a merchant complaining that Wickfire violated trademark terms and plagiarized TriMax’s ads;
  • A lengthy technical report that, according to a world-renowned computer expert, proves conclusively that Wickfire committed extensive click fraud against TriMax;
  • A real-time video demonstrating the bid-jamming TriMax experienced;
  • A summary of hundreds of TriMax’s merchant contracts interfered with by bid-jamming; and
  • E-mails from other competitors of Wickfire complaining about Wickfire’s bidding tactics.

Despite the jury’s finding against Wickfire, Chet Hall, and Jon Brown for intentional interference with TriMax’s business, no damages against Wickfire were awarded. This was, as the District Court noted, a finding reached by the jury after “the jury heard evidence that Google investigated Wickfire’s AdWords bidding and determined it was permissible.”

However, the District Court’s Final Judgment did not disturb the jury’s finding that Wickfire, Chet Hall, and Jon Brown committed the intentional interference in the first place. Thus, the interference finding against Wickfire, Chet Hall, and Jon Brown stands and is final.

Prior to issuing the “TAKE NOTHING” judgment and dismissing Wickfire’s meritless claims permanently, a Magistrate Judge considered a motion to disqualify Wickfire attorney, Katy Hall (formerly known as Katy Atlas). TriMax alleged that while in possession of TriMax’s sensitive documents, Katy Hall began a personal and intimate relationship with Chet Hall (CEO and Co-Founder of Wickfire, and, himself a party to the case), divorced her prior husband, had a child with Chet Hall, and married Chet Hall after he divorced his prior wife. TriMax also alleged that Katy Hall wrongfully accepted an in-house position with Wickfire while in possession of the documents. Katy Hall is currently Chief Operating Officer of Wickfire’s BuyersGuide.org. A Magistrate Judge however, ruled that TriMax could not “meet its heavy burden to prove that disqualification is warranted” and denied the motion to disqualify Katy Hall.

TriMax’s CEO, Laura Woodruff, commented: “After the Fifth Circuit exonerated TriMax in 2021, we were surprised that Wickfire chose to continue asserting meritless claims with the District Court. However, we are pleased with the recent orders by the District Court, which—like the Appellate Court before it—repeatedly rejected Wickfire’s claims for lack of merit. We are, however, still disappointed that Google and the Networks permitted Wickfire to intentionally interfere with TriMax’s business in the first place. Nevertheless, based on the jury’s finding that Wickfire interfered with TriMax’s business—a finding that was not reversed or altered by the recent Final Judgment—we now hope tactics like impersonation of competitors, kickbacks, bid jamming, and click fraud, will no longer be tolerated in the online advertising industry.”

About TriMax Media:

Founded in 2003, TriMax Media is a digital marketing agency specializing in performance-based search engine marketing. TriMax served on the first Google Advertiser Research Council and was one of the first companies to generate over one million leads for its clients utilizing Google AdWords. The agency focuses on creating highly effective search marketing campaigns and developing successful long-term relationships with its clients.

Company Contact:

For questions, please contact:
Barry M. Golden
Egan Nelson LLP
214.893.9034
barry.golden@egannelson.com

Bright Peak Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting

–Oral Presentation to highlight the creation of next-generation biologics using a novel chemistry platform technology—

–Poster presentation describing the cis-activation of PD-1+ effector T cells with dual-targeting immunocytokines generated using a novel chemical conjugation platform—

–Poster presentation to demonstrate the power of our novel chemical protein synthesis technology by engineering a pleiotropic native cytokine into an optimized cancer therapeutic—

SAN DIEGO and BASEL, Switzerland, April 04, 2022 (GLOBE NEWSWIRE) — Bright Peak Therapeutics, a biotechnology company developing next-generation cytokine immunotherapies to treat cancer and autoimmune disease, today announced the acceptance of one oral presentation and two poster presentations at the American Association for Cancer Research (AACR) Annual Meeting taking place April 8-13, 2022, in New Orleans, Louisiana.

“We’re thrilled to present details on the broad applications of Bright Peak’s innovative chemical protein synthesis and conjugation technology at AACR 2022,” said Fredrik Wiklund, President and CEO. “This is the first time we are showcasing our novel platform at such an important scientific meeting, and we look forward to contributing to the advancement of immunomodulatory cancer agents and interventions through our highly differentiated approach.”

Details of the abstracts and presentations are as follows:

Oral Presentation:  Creating next-generation biologics using a novel chemistry platform technology
Minisymposium MS.CH01.01: Drug Design and Lead Optimization Strategies Toward Novel or Difficult-to-Drug Cancer Targets
Date and Time: April 11, 2022, 3:50 – 4:05 PM (CDT)

Title:  Cis-activation of PD-1+ effector T cells with dual-targeting immunocytokines generated using a novel chemical conjugation platform
Session Title: Immunomodulatory Agents and Interventions 3
Date and Time:  April 13, 2022, 9:00 AM – 12:30 PM (CDT)
Abstract Number: 4223, Section 38

Abstract Highlights: Bright Peak has developed a cell-free chemical protein synthesis and conjugation platform to rapidly generate optimized antibody-cytokine (immunocytokine) therapeutics within weeks. The Bright Peak immunocytokine platform features flexible “plug and play” technology whereby our enhanced cytokine payloads are chemically conjugated to existing antibodies obtained “off the shelf”. Bright Peak generates enhanced and conjugatable cytokine payloads using a novel protein engineering platform based on solid-phase peptide synthesis and subsequent chemical ligation of protein segments and protein folding. Our cytokine payloads are designed with optimized properties and conjugation handles during chemical synthesis and are then readily chemically conjugated to specific lysine residues in the Fc region of an existing IgG1, IgG2 or IgG4 antibody without the need for prior antibody engineering.

We are initially focusing on the development of PD-1-targeted immunocytokines (ICs) that dual-target PD-1+ effector T cells (cis-signaling) to achieve potent and selective activation of tumor antigen-experienced effector T cells. Resulting PD-1/IL-2 ICs are highly active showing significantly enhanced potency due to avidity resulting from binding of the cytokine payload to PD-1+ effector T cells in cis. Our PD-1/IL-2 ICs induce strong pharmacodynamic effects in vivo, and we are currently optimizing the pharmacological profiles of PD-1-targeted immunocytokines for clinical application.

Title:  BPT-143: A fully synthetic alpha-dead IL-2 with a best-in-class preclinical pharmacodynamic and efficacy profile supporting first-in-human clinical development
Session Title: Immunomodulatory Agents and Interventions 3
Date and Time:  April 13, 2022, 9:00 AM – 12:30 PM (CDT)
Abstract Number: 4224, Section 38

Abstract Highlights: As a proof of concept for our chemical protein synthesis platform, we set out to engineer a variant of human IL-2 that solves the major limitations of immuno-oncology therapeutics based on wildtype IL-2 (e.g, aldesleukin). Using our chemical protein synthesis technology, we rationally designed an enhanced cytokine payload with select modified amino acids to introduce site-specific chemical conjugation handles and specific sequence variations to optimize the biological properties of IL-2 for cancer therapy while maintaining high homology to the wildtype IL-2 sequence. Bright Peak’s enhanced cytokine payload is engineered for increased binding to CD122/IL2Rβ and does not interact with CD25/IL2Rα to improve safety and prevent the preferential activation of Tregs compared to CD8+ T effector cells. The fully synthetic cytokine payload can then be conjugated to a 30 kDa PEG for optimal pharmacokinetic properties or to a monoclonal antibody to create a novel Bright Peak immunocytokine.

We successfully manufactured our full-length, folded and PEGylated protein (BPT-143) under GMP conditions to amounts sufficient for clinical development. BPT-143 demonstrates the power of our synthetic protein synthesis platform to engineer pleiotropic native cytokines into optimized therapeutics and are exploiting our technology to develop a pipeline of novel designer cytokines and multi-modal immune therapies.

The abstracts can be accessed through the AACR meeting planner and are available for viewing online here:

https://www.abstractsonline.com/pp8/#!/10517/presentation/13210

https://www.abstractsonline.com/pp8/#!/10517/presentation/17093

https://www.abstractsonline.com/pp8/#!/10517/presentation/17115

About Bright Peak Therapeutics
Bright Peak is a privately held biotechnology company based in Basel, Switzerland and San Diego, USA. We use our unique ability to chemically synthesized natively folded proteins to create a portfolio of designer immunotherapies for the treatment of cancer and autoimmune diseases. Our pipeline stretches from discovery to IND-enabling and encompasses half-life extended cytokines, antibody-cytokine conjugates and other novel formats. Bright Peak is funded by a syndicate of leading healthcare investors.

Contact:
info@brightpeaktx.com

Point of Care and Rapid Diagnostics Market worth $72.0 billion by 2027 – Exclusive Report by MarketsandMarkets™

The Latin America market is expected to grow at the highest CAGR during the forecast period

Northbrook, April 04, 2022 (GLOBE NEWSWIRE) — According to the new market research report Point of Care and Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) – Global Forecast to 2027″, published by MarketsandMarkets™, the global Point of Care Diagnostics Market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027.

Browse in-depth TOC on “Point of Care and Rapid Diagnostics Market”
269 – Tables
42 – Figures
344 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185

The Rapid Diagnostics Market growth is mainly driven by the high prevalence of infectious diseases, supportive government policies and rising number of CLIA-waived POC tests. In addition, healthcare decentralization and greater investments and funding for product development are expected to offer growth opportunities for players in the POC Diagnostics Market. However, issues related to pricing pressure owing to reimbursement cuts and budget constraints are expected to hinder the growth of the point of care diagnostics market during the forecast period.

The Glucose Monitoring Products segment accounted for the largest share of the point of care diagnostics market, by product type, in 2021

Based on products, the Point of Care and Rapid Diagnostics Market is segmented into glucose monitoring products, cardiometabolic monitoring products, COVID-19 testing products, infectious disease testing products, coagulation monitoring products, pregnancy & fertility testing products, hematology testing products, tumor/cancer marker testing products, fecal occult testing products, urinalysis testing products, drug-of-abuse testing products, cholesterol testing products, and other products. In 2021, the glucose monitoring products segment accounted for the largest share of the Rapid Diagnostics Market. This can be attributed to the growing diabetic patient population base, ongoing technological advancements, and the growing preference for home glucose testing.

The Lateral Flow Assays segment accounted for the largest share of the point of care diagnostics market, by platform, in 2021

Based on platform, the point-of-care diagnostics market is segmented into lateral flow assays, immunoassays, microfluidics, dipsticks, and molecular diagnostics. The lateral flow assays segment accounted for the largest share of the market in 2021. The widespread adoption of lateral flow assays in POC testing as a replacement for lengthy, conventional laboratory procedures is a key factor contributing to the growth of this segment.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=106829185

The OTC Testing Products segment, by mode of purchase, accounted for the largest share of the global point of care diagnostics market in 2021

On the basis of mode of purchase, the point-of-care diagnostics market is segmented into OTC testing products and prescription-based testing products. The OTC testing products segment accounted for the largest share of the market in 2021. The growing prevalence of lifestyle diseases and the favorable reimbursement scenario for OTC testing products are the major factors driving the growth of this market segment.

On the basis of End Users, Hospitals & Critical Care Centers segment accounted for the largest share of the global point of care diagnostics market, in 2021

On the basis of end users, the Point of Care and Rapid Diagnostics Market is segmented into clinical laboratories; ambulatory care facilities and physicians’ offices; pharmacies, retail clinics, and E-commerce platforms; hospitals, critical care centers, and urgent care centers; home care & self-testing; and other end users. The hospitals & critical care centers segment is expected to dominate the market during the forecast period, owing to the increasing adoption of POC devices offering reduced turnaround time. The clinical laboratories segment accounted for the largest share of the Rapid Diagnostics Market in 2021. However, the home care and self-testing segment is projected to register the highest CAGR during the forecast period, owing to the increasing prevalence of chronic diseases (requiring long-term care and frequent monitoring), growing awareness about home care, and the increasing availability of user-friendly and advanced POC diagnostic products.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=106829185

The Latin America market is expected to grow at the highest CAGR during the forecast period

The global point of care diagnostics market is segmented into North America (comprising the US and Canada), Europe (includes Germany, France, and the UK), the Asia Pacific (includes Japan, China, India), Latin America (Brazil, Mexico), and the Middle East & Africa. In 2021, North America accounted for the largest share of this market, followed by Europe. The rising prevalence of lifestyle diseases, growing number of product approvals, and government initiatives to support the wider adoption of POC testing products are the key factors driving the growth of the North American point-of-care diagnostics market.

On the other hand, the Latin American market is projected to register the highest growth during the forecast period due to government efforts to increase awareness about the early detection of diseases and regular health check-ups, further promoting point-of-care devices. Moreover, increasing healthcare expenditures, growing number of hospitals and clinical diagnostic laboratories, and increasing collaborations among players in the region are also expected to drive market growth.

As of 2020, the point of care diagnostics market is dominated by Roche Diagnostics (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), Quidel Corporation (US). Other leading players are Becton, Dickinson, and Company (US), Biomeriux S.A. (France), and Chembio Diagnostics (US).

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Sportradar Files Its Annual Report on Form 20-F

ST. GALLEN, Switzerland, April 04, 2022 (GLOBE NEWSWIRE) — Sportradar Group AG (NASDAQ: SRAD) (the “Company”), the leading global technology company enabling next generation engagement in sports, and the number one provider of business-to-business solutions to the global sports betting industry, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2021 with the Securities and Exchange Commission on March 31, 2022. The annual report on Form 20-F can be accessed on the Company’s investor relations website at https://investors.sportradar.com/financials-filings/sec-filings or on the SEC’s website at www.sec.gov.

The Company will provide a paper copy of the annual report containing its audited consolidated financial statements, free of charge, to its shareholders upon request. Requests should be directed in writing by email to investor.relations@sportradar.com or by post to Sportradar Group AG, Feldlistrasse 2, 9000 St. Gallen, Switzerland.

About Sportradar

Sportradar is the leading global sports technology company creating immersive experiences for sports fans and bettors. Established in 2001, the company is well-positioned at the intersection of the sports, media and betting industries, providing sports federations, news media, consumer platforms and sports betting operators with a range of solutions to help grow their business. Sportradar employs more than 2,900 full time employees across 20 countries around the world. It is our commitment to excellent service, quality and reliability that makes us the trusted partner of more than 1,700 customers in over 120 countries and an official partner of the NBA, NHL, MLB, NASCAR, UEFA, FIFA, ICC and ITF. We cover more than 890,000 events annually across 92 sports. With deep industry relationships, Sportradar is not just redefining the sports fan experience; it also safeguards the sports themselves through its Integrity Services division and advocacy for an integrity-driven environment for all involved.

CONTACT

Investor Relations:
Rima Hyder
investor.relations@sportradar.com

Press Contact:
Sandra Lee
comms@sportradar.com

Indonesia teacher given death sentence for raping 13 pupils

Published by
Al-Araby

An Indonesian teacher found guilty of raping 13 students at an Islamic boarding school, and who impregnated at least eight of the victims, was sentenced to death on Monday. Herry Wirawan, 36, had been sentenced to life in prison in February, in a case that drew national attention to sexual abuse in Indonesia’s religious schools. But prosecutors, who had requested the death penalty and chemical castration, filed an appeal. “We accept the appeal of the prosecutors,” read the judge’s statement, published on Monday on the website of the High Court in Bandung, West Java province. “We hereby punish … Continue reading “Indonesia teacher given death sentence for raping 13 pupils”

For Indonesians, palm oil is everywhere but on supermarket shelves

Published by
Mongabay

JAKARTA — Cartel practices have been blamed for a scarcity of cooking oil in the world’s top producer of palm oil — but government policies seen as coddling the industry have also come under scrutiny. Households across Indonesia have since last October experienced acute shortages of cooking oil. Even when supplies have been available, prices have often been multiples of what the product would usually retail for. The scarcity has prompted widespread complaints from regular citizens and from politicians, with parliament launching hearings into why Indonesia, which produces more than half of the … Continue reading “For Indonesians, palm oil is everywhere but on supermarket shelves”

Industry 4.0 Market worth $165.5 billion by 2026

IoT is expected to hold largest market share of industry 4.0 market during forecasted period

Northbrook, April 04, 2022 (GLOBE NEWSWIRE) — According to the new market research report Industry 4.0 Market by Technology (Industrial Robots, Blockchain, Industrial Sensors, Industrial 3D Printing, Machine Vision, HMI, AI in Manufacturing, Digital Twin, AGVs, Machine Condition Monitoring) and Geography – Global Forecast to 2026″, The industry 4.0 market is projected to grow from USD 64.9 billion in 2021 to USD 165.5 billion by 2026; it is expected to grow at a CAGR of 20.6%from 2021 to 2026.

Browse in-depth TOC on “Industry 4.0 Market”

188 Tables

88 Figures 

339 Pages 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102536746

Increasing adoption of the industrial internet worldwide in manufacturing units and growing focus on enhanced efficiency of machinery and systems and reduced production costs play a significant role in the growth of the market worldwide. Also, the growing demand for industrial robotics is expected to fuel the growth of the Industry 4.0 market

5G Market is expected to commercialize in late 2019 and is expected to grow at highest CAGR during forecasted period.

The speed and reliability of 5G are expected to have a massive impact on M2M and IoT. Key reasons for the increased adoption of new M2M technologies are better connectivity for smooth communication and low power requirement. To achieve effective machine-to-machine communication, the existing capacity of mobile networks must be able to handle billions of nodes that are expected to ascend in the next couple of years. Currently, the network capacity is inefficient to handle M2M and human-based communications, as well as their different communication patterns such as latency time.

IoT is expected to hold largest market share of industry 4.0 market during forecasted period

Internet of Things (IoT) in the industrial sector, has given rise to a new concept known as the Industrial Internet of Things (IIoT), also known as Industrial Internet or Industry 4.0. IoT in the industrial sector brings together advancements of two transformative revolutions, namely, the countless machines, facilities, fleets, and networks that emerged from the industrial revolution and the more recent powerful advancements in computing, information, and communication systems brought about by the internet revolution.

Request a Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=102536746

APAC is expected to hold largest market share of Industry 4.0 market during forecasted period

An increase in the adoption of robotics in countries such as China, Japan, and South Korea is among the major factors leading to the growth of the Industry 4.0 market in APAC. Also, low production cost in APAC countries enables manufacturers to set up manufacturing facilities in this region. APAC is projected to grow at the fastest rate, considering continuous technological advancements and financial support from the governments in the region, as well as extensive industrial base, with Japan and China being the major contributors. China has been working on an innovative industrial practice by implementing automation technologies in manufacturing companies.

The major players in the Industry 4.0 market are ABB (Switzerland), Mitsubishi (Japan), Yaskawa (Japan), KUKA (Germany), FANUC (Japan), General Electric (US), IBM (US), Cisco (US), Microsoft (US), Stratasys (US), Google (US), Intel (US), HP (US), Siemens (Germany), Ansys (US), AIBrain (US), SAP (US), Amazon Web Services (US), and General Vision (US).

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

 

3air opens final presale round ahead of token launch, expands partnerships in Africa

The 3air token is offered at $0.06 during the presale, ahead of the token listing at $0.075

DUBAI, United Arab Emirates, April 04, 2022 (GLOBE NEWSWIRE) — (via Blockchain Wire3air, the blockchain-based internet startup that aims to bring high-speed broadband internet access, blockchain and DeFi to Africa, is continuing its expansion into new partnerships with African governments and organizations. This comes at the same time as 3air prepares for its token launch, which is set to list on several launchpads and decentralized exchanges this month.

Expanding partnerships in Africa

The Africa Chamber of Digital Commerce (ACOFDC) announced the partnership between the ACOFDC, 3air and the Nigerian Ministry of Communications and Digital Economy during the ACOFD Summit ’22 that took place in Dubai in March 2022. Together, they will power the “ACOFDC mesh No-code Low-Code Visual Programming technology training program” that aims to train and certify 3.5 million African youth in Dittofi no-code visual programming with the purpose of tackling unemployment and accelerating inclusive digital economy in Africa.

“The 3air team is excited to work with the ACOFDC and the Nigerian Ministry of Communications and Digital Economy to educate millions of aspiring Africans in tech. We believe that educating and empowering upcoming talent is the key to creating strong digital economies in Africa and helping to create jobs for African youth,” said 3air CEO, Sandi Bitenc.

Using the Blockchain to bridge the digital divide in Africa

In addition to forming partnerships and supporting educational programs, 3air’s focus is bringing high-speed broadband internet access to all. This will in turn open up the world of blockchain and DeFi to millions of people and businesses who are currently not connected to the internet.

Once users are onboarded on the 3air platform, they have access to DeFi and online banking, and can create their own decentralized digital identities to access life-enhancing services on the blockchain. 3air is committed to using the blockchain to bridge the digital divide in Africa and help empower Africans with the tools they need to participate in the global economy.

Final round of token presale open

3air is preparing for its token launch this month, which will list on several launchpads and decentralized exchanges. The token is currently available for $0.06 in its final presale round taking place from March 31 – April 7, 2022, before it gets listed on DEXes at $0.075.

To grow and incentivize its community, the company is hosting large-bounty airdrops and giveaways. Prizes include a Macbook Air and 175.000 3air tokens to be distributed across the winners.

About 3air

3air brings millions of users online and into the world of blockchain and DeFi with its blockchain-based internet platform. It uses proprietary technology to build broadband infrastructure where it does not exist and enables access to the 3air blockchain platform that offers DeFi, banking, and several income-generating and reward mechanisms to users.

For more information, visit 3air.io or follow 3air on Twitter at @3aircrypto.

Website: https://3air.io/

Docs: https://docs.3air.io/

Deck: https://docs.3air.io/pdf/3air_deck.pdf

Whitepaper: https://docs.3air.io/pdf/3air_whitepaper.pdf

Twitter: https://twitter.com/3aircrypto

Instagram: https://www.instagram.com/3air.crypto/

Youtube: https://www.youtube.com/c/3aircrypto

Tiktok: https://www.tiktok.com/@3aircrypto

Telegram: https://t.me/my3air

Discord: https://discord.com/invite/3air

Contact:

Ruba Aramouny

Head of Marketing & PR

3air Tech Ltd

Ruba (at) 3air.io